A Case Report of Burning Mouth Syndrome Treated with Individualised HomeopathyFunding No funding was obtained for this case report or the preparation of the manuscript.
08. April 2019
02. Juni 2019
10. September 2019 (online)
Introduction Burning mouth syndrome (BMS) is a rare disease of unknown origin. No efficient treatment is known, and integrative approaches are warranted. So far, individualised homeopathy (iHOM) has not been evaluated or reported in any peer-reviewed journal as a treatment option.
Methods At the Centre of Complementary Medicine at a university institute in Switzerland, a 38-year-old patient with BMS and various co-morbidities was treated with iHOM between July 2014 and August 2018. The treatment involved prescription of individually selected homeopathic single remedies. During follow-up visits, outcome was assessed with two validated questionnaires concerning patient-reported outcomes. To assess whether the documented changes were likely to be associated with the homeopathic intervention, an assessment using the modified Naranjo criteria was performed.
Results Over an observation period of 4 years, an increasingly beneficial result from iHOM was noted for oral dysaesthesia and pains as well as for the concomitant symptoms.
Conclusion Considering the multi-factorial aetiology of BMS, a therapeutic approach such as iHOM that integrates the totality of symptoms and complaints of a patient might be of value in cases where an association of psychological factors and the neuralgic complaints is likely.
• During the course of treatment, validated questionnaires were used for the documentation of the results and details on the homeopathic prescriptions were given alongside the conventional treatments.
• There was a likely causative correlation between the received treatment and the clinical outcome of the patient.
Availability of Data and Materials
Data for this report are confidential. Anonymised material may be obtained from the author.
Ethics Approval and Consent to Participate
Approval of the Ethics Committee of Bern Canton was obtained with the request ID 2017–00848, after receiving the patient's consent that the coded case data would be summarised and evaluated.
Consent for Publication
Informed consent for publication was given by the patient. The signed document is confidential.
Dr. K. Gaertner was responsible for data documentation and the preparation of the manuscript. Dr. M. Frei-Erb supervised the first author and added to the manuscript.
- 1 Evans RW, Drage LA. Burning mouth syndrome. Headache 2005; 45: 1079-1081
- 2 Steele JC. The practical evaluation and management of patients with symptoms of a sore burning mouth. Clin Dermatol 2016; 34: 449-457
- 3 Kohorst JJ, Bruce AJ, Torgerson RR, Schenck LA, Davis MDP. The prevalence of burning mouth syndrome: a population-based study. Br J Dermatol 2015; 172: 1654-1656
- 4 Forssell H, Jääskeläinen S, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002; 99: 41-47
- 5 Grushka M, Ching V, Epstein J. Burning mouth syndrome. Adv Otorhinolaryngol 2006; 63: 278-287
- 6 Jääskeläinen SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol 2012; 123: 71-77
- 7 Galli F, Lodi G, Sardella A, Vegni E. Role of psychological factors in burning mouth syndrome: a systematic review and meta-analysis. Cephalalgia 2017; 37: 265-277
- 8 Liu YF, Kim Y, Yoo T, Han P, Inman JC. Burning mouth syndrome: a systematic review of treatments. Oral Dis 2018; 24: 325-334
- 9 Sardella A, Lodi G, Demarosi F, Bez C, Cassano S, Carrassi A. Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments. Oral Dis 2006; 12: 152-155
- 10 Raak C, Büssing A, Gassmann G, Boehm K, Ostermann T. A systematic review and meta-analysis on the use of Hypericum perforatum (St. John's Wort) for pain conditions in dental practice. Homeopathy 2012; 101: 204-210
- 11 Chebel IFO. Ação do tratamento homeopático na sintomatologia da síndrome da ardência bucal em duas fases: estudo duplo cego placebo controlado e estudo aberto [Action of homeopathic treatment in the symptoms of oral burning syndrome in two phases: double-blind placebo-controlled study and open study]. São Paolo: University of São Paolo; 2013
- 12 Hahnemann S. Organon der Heilkunst. [Hahnemann's Organon of Medicine]. Standard edition of 6th ed. In: Schmidt JM. , ed. Heidelberg: Haug; 1996/1999; 388
- 13 van Grinsven E, van Zandvoort R. . Complete Dynamics – Practitioner Edition. Available at: www.completedynamics.com . Accessed during the period 2013 to 2018
- 14 van Haselen RA. Homeopathic clinical case reports: development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; 25: 78-85
- 15 Kent JT. Lectures on Homoeopathic Philosophy. 7th ed. New Delhi: B Jain; 2018: 342
- 16 Paterson C. Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey. BMJ 1996; 312: 1016-1020
- 17 Reilly D, Mercer SW, Bikker AP, Harrison T. Outcome related to impact on daily living: preliminary validation of the ORIDL instrument. BMC Health Serv Res 2007; 7: 139
- 18 Stub T, Kristoffersen AE, Alræk T, Musial F, Steinsbekk A. Risk in homeopathy: classification of adverse events and homeopathic aggravations – a cross sectional study among Norwegian homeopath patients. Complement Ther Med 2015; 23: 535-543
- 19 U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events v5.0 (CTCAE). National Institutes of Health: National Cancer Institute; 2017 . Available at: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5×7.pdf . Accessed May 15, 2019
- 20 Stub T, Musial F, Kristoffersen AA, Alræk T, Liu J. Adverse effects of homeopathy, what do we know? A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 2016; 26: 146-163
- 21 Frass M, Friehs H, Thallinger C. , et al. Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients – a pragmatic randomized controlled trial. Complement Ther Med 2015; 23: 309-317
- 22 Macías-Cortés EC, Llanes-González L, Aguilar-Faisal L, Asbun-Bojalil J. Individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP study): a randomized, double-dummy, double-blind, placebo-controlled trial. PLoS One 2015; 10: e0118440
- 23 Adler UC, Paiva NM, Cesar AT. , et al. Homeopathic individualized Q-potencies versus fluoxetine for moderate to severe depression: double-blind, randomized non-inferiority trial. Evid Based Complement Alternat Med 2011; 2011: 520182
- 24 Coculescu EC, Radu A, Coculescu BI. Burning mouth syndrome: a review on diagnosis and treatment. J Med Life 2014; 7: 512-515